精神心理科指南

订阅

MedSci主页 / 所有栏目 / 精神心理科指南

2021 UKAAN共识声明：成人ADHD患者职业治疗干预建议

2021-02-04 BMC Psychiatry . 2021 Feb 4;21(1):72.

注意缺陷多动障碍

2021年2月，英国成人ADHD网(UKAAN)发布了成人ADHD患者职业治疗干预建议共识声明。注意缺陷多动障碍（ADHD）是一种延续到成年的神经发育障碍，其治疗方式主要是药物和心律治疗，职业疗法尚未

中文标题：

2021 UKAAN共识声明：成人ADHD患者职业治疗干预建议

英文标题：

Recommendations for occupational therapy interventions for adults with ADHD: a consensus statement from the UK adult ADHD network

发布机构：

发布日期：

2021-02-04

简要介绍：

2021年2月，英国成人ADHD网(UKAAN)发布了成人ADHD患者职业治疗干预建议共识声明。注意缺陷多动障碍（ADHD）是一种延续到成年的神经发育障碍，其治疗方式主要是药物和心律治疗，职业疗法尚未得到充分的描述。本文主要针对成人ADHD患者职业治疗干预的相关内容提供指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 UKAAN共识声明：成人ADHD患者职业治疗干预建议.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c80b21c002060105, title=2021 UKAAN共识声明：成人ADHD患者职业治疗干预建议, enTitle=Recommendations for occupational therapy interventions for adults with ADHD: a consensus statement from the UK adult ADHD network, guiderFrom=BMC Psychiatry . 2021 Feb 4;21(1):72., authorId=0, author=, summary=2021年2月，英国成人ADHD网(UKAAN)发布了成人ADHD患者职业治疗干预建议共识声明。注意缺陷多动障碍（ADHD）是一种延续到成年的神经发育障碍，其治疗方式主要是药物和心律治疗，职业疗法尚未, cover=https://img.medsci.cn/2021214/1613236317291_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Thu Feb 04 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年2月，英国成人ADHD网(UKAAN)发布了成人ADHD患者职业治疗干预建议共识声明。注意缺陷多动障碍（ADHD）是一种延续到成年的神经发育障碍，其治疗方式主要是药物和心律治疗，职业疗法尚未得到充分的描述。本文主要针对成人ADHD患者职业治疗干预的相关内容提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=9751, tagName=注意缺陷多动障碍)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=9751, guiderKeyword=注意缺陷多动障碍, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8977, appHits=56, showAppHits=0, pcHits=696, showPcHits=8921, likes=0, shares=14, comments=4, approvalStatus=1, publishedTime=Sun Feb 14 01:22:16 CST 2021, publishedTimeString=2021-02-04, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Feb 14 01:12:03 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 00:53:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 UKAAN共识声明：成人ADHD患者职业治疗干预建议.pdf)])
2021 UKAAN共识声明：成人ADHD患者职业治疗干预建议.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2106856, encodeId=dd2a2106856b9, content=发育障碍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd055473428, createdName=ms3000000604700617, createdTime=Tue Dec 20 20:26:34 CST 2022, time=2022-12-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=951237, encodeId=142095123ed7, content=感谢分享，及时知识点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Thu Mar 25 18:09:37 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924669, encodeId=0a3a924669cd, content=多动症, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Mon Feb 15 08:01:36 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924523, encodeId=7e0792452322, content=最新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210214/06faf1dcd3d24cf8b62c33281fd8c3ae/136ded9bdd9c44c4a4ceffc8b91f6b35.jpg, createdBy=2c625460184, createdName=ms4000000115843104, createdTime=Sun Feb 14 08:20:25 CST 2021, time=2021-02-14, status=1, ipAttribution=)]
    2022-12-20 ms3000000604700617 来自湖南省

    发育障碍

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2106856, encodeId=dd2a2106856b9, content=发育障碍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd055473428, createdName=ms3000000604700617, createdTime=Tue Dec 20 20:26:34 CST 2022, time=2022-12-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=951237, encodeId=142095123ed7, content=感谢分享，及时知识点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Thu Mar 25 18:09:37 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924669, encodeId=0a3a924669cd, content=多动症, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Mon Feb 15 08:01:36 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924523, encodeId=7e0792452322, content=最新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210214/06faf1dcd3d24cf8b62c33281fd8c3ae/136ded9bdd9c44c4a4ceffc8b91f6b35.jpg, createdBy=2c625460184, createdName=ms4000000115843104, createdTime=Sun Feb 14 08:20:25 CST 2021, time=2021-02-14, status=1, ipAttribution=)]
    2021-03-25 ms1000000580800231

    感谢分享，及时知识点

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2106856, encodeId=dd2a2106856b9, content=发育障碍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd055473428, createdName=ms3000000604700617, createdTime=Tue Dec 20 20:26:34 CST 2022, time=2022-12-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=951237, encodeId=142095123ed7, content=感谢分享，及时知识点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Thu Mar 25 18:09:37 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924669, encodeId=0a3a924669cd, content=多动症, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Mon Feb 15 08:01:36 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924523, encodeId=7e0792452322, content=最新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210214/06faf1dcd3d24cf8b62c33281fd8c3ae/136ded9bdd9c44c4a4ceffc8b91f6b35.jpg, createdBy=2c625460184, createdName=ms4000000115843104, createdTime=Sun Feb 14 08:20:25 CST 2021, time=2021-02-14, status=1, ipAttribution=)]
    2021-02-15 carrotlyl

    多动症

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2106856, encodeId=dd2a2106856b9, content=发育障碍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd055473428, createdName=ms3000000604700617, createdTime=Tue Dec 20 20:26:34 CST 2022, time=2022-12-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=951237, encodeId=142095123ed7, content=感谢分享，及时知识点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=459d5467529, createdName=ms1000000580800231, createdTime=Thu Mar 25 18:09:37 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924669, encodeId=0a3a924669cd, content=多动症, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Mon Feb 15 08:01:36 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924523, encodeId=7e0792452322, content=最新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210214/06faf1dcd3d24cf8b62c33281fd8c3ae/136ded9bdd9c44c4a4ceffc8b91f6b35.jpg, createdBy=2c625460184, createdName=ms4000000115843104, createdTime=Sun Feb 14 08:20:25 CST 2021, time=2021-02-14, status=1, ipAttribution=)]
    2021-02-14 ms4000000115843104

    最新

    0

相关指南

2020 专家共识：女孩和女性注意缺陷多动障碍的识别和管理

国外精神科相关专家小组（统称） · 2020-08-10

拓展阅读

2020 专家共识：女孩和女性注意缺陷多动障碍的识别和管理

国外精神科相关专家小组（统称） · 2020-08-10

注意缺陷多动障碍（ADHD）药物临床试验技术指导原则（征求意见稿）

国家药品监督管理局药品审评中心（CDE） · 2021-04-22

注意缺陷多动障碍（ADHD）药物临床试验技术指导原则（试行）

国家药品监督管理局药品审评中心（CDE） · 2021-10-01

注意缺陷/多动障碍中药临床试验设计与评价技术指南

中华中医药学会儿科分会 · 2021-09-06

学龄前注意缺陷多动障碍儿童实施行为管理的专家共识

南京医科大学附属脑科医院 · 2022-08-25

咖啡因摄入对注意缺陷多动障碍 (ADHD) 治疗的影响：动物研究的系统综述

暂未更新 · 2022-02-10